Sunnybrook Research Institute
Toronto, Ontario, M4N 3M5, Canada
Location status: Recruiting
NCT Number: NCT07279714
This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.
Interested in participating?
Request Info60 year and older
All sexes
Interventional
Phase 2
Toronto, Ontario, M4N 3M5, Canada
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fisetin 20mg/kg/day
Time frame: 30 days
Measured using AE reports
Contact information is provided by the study sponsor or research team.
Sunnybrook Health Sciences Centre
Other
Fisetin Intervention Study in Mild Alzheimer's Disease
Acronym: FIS-AD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07279740
Alzheimer Dementia, Alzheimer Dementia (AD)
Toronto, Ontario, Canada
View Trial DetailsNCT07693140
Alzheimer, Alzheimer Dementia
Winter Park, Florida, United States
View Trial DetailsNCT07604896
Alzheimer Dementia (AD), Alzheimer Disease
Wenzhou, Zhejiang, China
View Trial DetailsNCT07701161
Alzheimer Disease, Alzheimer s Disease
Chicago, Illinois, United States
View Trial Details